IntelGenx Technologies Corp.
IGXT
$0.167
-$0.0065-3.75%
| Weiss Ratings | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.49 | |||
| Price History | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -9.73% | |||
| 2-Year Total Return | -9.53% | |||
| 3-Year Total Return | -42.41% | |||
| 5-Year Total Return | 19.29% | |||
| 52-Week High % Change | -12.11% | |||
| 52-Week Low % Change | 19.67% | |||
| Price | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.19 | |||
| 52-Week Low Price | $0.14 | |||
| 52-Week Low Price (Date) | Apr 23, 2024 | |||
| 52-Week High Price (Date) | Apr 04, 2024 | |||
| Valuation | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 29.17M | |||
| Enterprise Value | 44.85M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | -1.86% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 27.83 | |||
| Price/Book (Q) | -1.90 | |||
| Enterprise Value/Revenue (TTM) | 42.68 | |||
| Price | $0.17 | |||
| Enterprise Value/EBITDA (TTM) | -4.81 | |||
| Enterprise Value/EBIT | -4.44 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 174.66M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (514) 331-7440 | |||
| Address | 6420 Abrams Montreal, QC H4S 1Y2 | |||
| Website | www.intelgenx.com | |||
| Country | Canada | |||
| Year Founded | 2003 | |||
| Profitability | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -961.65% | |||
| Profit Margin | -1,049.47% | |||
| Management Effectiveness | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -74.80% | |||
| Return on Equity | -- | |||
| Income Statement | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.05M | |||
| Total Revenue (TTM) | 1.05M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | -694.00K | |||
| EBITDA (TTM) | -9.33M | |||
| EBIT (TTM) | -10.11M | |||
| Net Income (TTM) | -11.03M | |||
| Net Income Avl. to Common (TTM) | -11.03M | |||
| Total Revenue Growth (Q YOY) | 7.41% | |||
| Earnings Growth (Q YOY) | -37.72% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | -38.32% | |||
| Balance Sheet | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 772.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 2.08M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -15.37M | |||
| Current Ratio (Q) | 0.126 | |||
| Book Value Per Share (Q) | -$0.09 | |||
| Total Assets (Q) | 6.55M | |||
| Total Current Liabilities (Q) | 16.52M | |||
| Total Debt (Q) | 16.46M | |||
| Total Liabilities (Q) | 21.91M | |||
| Total Common Equity (Q) | -15.37M | |||
| Cash Flow | IGXT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.25M | |||
| Cash from Financing (TTM) | 4.07M | |||
| Net Change in Cash (TTM) | -1.75M | |||
| Levered Free Cash Flow (TTM) | -2.94M | |||
| Cash from Operations (TTM) | -7.12M | |||
